{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:40:38Z","timestamp":1790095238311,"version":"4.0.1"},"reference-count":64,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:p>Lipodystrophy syndromes are conditions in which the adipose tissue mass of an individual is altered inappropriately. The change in adipose mass can range from a relatively modest and subtle redistribution in some individuals with partial lipodystrophy to a near-complete absence of adipose tissue in the most severe forms of generalized lipodystrophy. The common feature is a disconnection between the need of the individual for a safe, healthy lipid storage capacity and the available adipose mass to perform this critical role. The inability to partition lipids for storage in appropriately functioning adipocytes leads to lipid accumulation in other tissues, which typically results in conditions such as diabetes, dyslipidemia, fatty liver, and cardiovascular disease. Several genes have been identified whose disruption leads to inherited forms of lipodystrophy. There is a link between some of these genes and adipose dysfunction, so the molecular basis of disease pathophysiology appears clear. However, for other lipodystrophy genes, it is not evident why their disruption should affect adipose development or function or, in the case of partial lipodystrophy, why only some adipose depots should be affected. Elucidating the molecular functions of these genes and their cellular and physiological effects has the capacity to uncover fundamental new insights regarding the development and functions of adipose tissue. This information is also likely to inform better management of lipodystrophy and improved treatments for patients. In addition, the findings will often be relevant to other conditions featuring adipose tissue dysfunction, including the more common metabolic disease associated with obesity.<\/jats:p>","DOI":"10.2337\/dbi21-0006","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T20:59:02Z","timestamp":1647982742000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":9,"title":["When Adipose Tissue Lets You Down: Understanding the Functions of Genes Disrupted in Lipodystrophy"],"prefix":"10.2337","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-4939","authenticated-orcid":false,"given":"Justin J.","family":"Rochford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"2022032220585798100_B1","first-page":"907","article-title":"Lipodistrophy: a paradigm for understanding the consequences of \u201coverloading\u201d adipose tissue","volume":"101","author":"Lim","year":"2021","journal-title":"Physiol Rev"},{"key":"2022032220585798100_B2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"key":"2022032220585798100_B3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.metabol.2015.06.004","article-title":"Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities","volume":"64","author":"Akinci","year":"2015","journal-title":"Metabolism"},{"key":"2022032220585798100_B4","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J Clin Invest"},{"key":"2022032220585798100_B5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mrrev.2019.03.005","article-title":"The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy","volume":"781","author":"Craveiro Sarmento","year":"2019","journal-title":"Mutat Res Rev Mutat Res"},{"key":"2022032220585798100_B6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1152\/physiolgenomics.00128.2017","article-title":"Mechanisms of allelic and clinical heterogeneity of lamin A\/C phenotypes","volume":"50","author":"Perovanovic","year":"2018","journal-title":"Physiol Genomics"},{"key":"2022032220585798100_B7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/ddi158","article-title":"Altered pre-lamin A processing is a common mechanism leading to lipodystrophy","volume":"14","author":"Capanni","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2022032220585798100_B8","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.yexcr.2011.09.012","article-title":"Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins","volume":"317","author":"Duband-Goulet","year":"2011","journal-title":"Exp Cell Res"},{"key":"2022032220585798100_B9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies","volume":"11","author":"Lloyd","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2022032220585798100_B10","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/hmg\/ddu728","article-title":"The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy","volume":"24","author":"Vadrot","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2022032220585798100_B11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1101\/gr.159400.113","article-title":"Lamin A\/C-promoter interactions specify chromatin state-dependent transcription outcomes","volume":"23","author":"Lund","year":"2013","journal-title":"Genome Res"},{"key":"2022032220585798100_B12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/19491034.2018.1449498","article-title":"Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation","volume":"9","author":"Briand","year":"2018","journal-title":"Nucleus"},{"key":"2022032220585798100_B13","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1083\/jcb.201701043","article-title":"A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic MIR335 locus","volume":"216","author":"Oldenburg","year":"2017","journal-title":"J Cell Biol"},{"key":"2022032220585798100_B14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1139\/bcb-2017-0210","article-title":"Lamin A\/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling","volume":"96","author":"Perepelina","year":"2018","journal-title":"Biochem Cell Biol"},{"key":"2022032220585798100_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0289-0","article-title":"Altered adipocyte differentiation and unbalanced autophagy in type 2 familial partial lipodystrophy: an in vitro and in vivo study of adipose tissue browning","volume":"51","author":"Pellegrini","year":"2019","journal-title":"Exp Mol Med"},{"key":"2022032220585798100_B16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1210\/jc.2018-01922","article-title":"Regional body fat changes and metabolic complications in children with dunnigan lipodystrophy-causing LMNA variants","volume":"104","author":"Patni","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022032220585798100_B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijms22105226","article-title":"Recent update on the molecular mechanisms of gonadal steroids action in adipose tissue","volume":"22","author":"Wawrzkiewicz-Ja\u0142owiecka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022032220585798100_B18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbalip.2019.02.002","article-title":"Gene-gene and gene-environment interactions in lipodystrophy: lessons learned from natural PPAR\u03b3 mutants","volume":"1864","author":"Broekema","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2022032220585798100_B19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ng.3700","article-title":"Prospective functional classification of all possible missense variants in PPARG","volume":"48","author":"Majithia","year":"2016","journal-title":"Nat Genet"},{"key":"2022032220585798100_B20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmet.2019.03.001","article-title":"Discovering metabolic disease gene interactions by correlated effects on cellular morphology","volume":"24","author":"Jiao","year":"2019","journal-title":"Mol Metab"},{"key":"2022032220585798100_B21","doi-asserted-by":"crossref","first-page":"34998","DOI":"10.1074\/jbc.M111.278853","article-title":"Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5)","volume":"286","author":"Gandotra","year":"2011","journal-title":"J Biol Chem"},{"key":"2022032220585798100_B22","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic challenge in PLIN1-associated familial partial lipodystrophy","volume":"104","author":"J\u00e9ru","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022032220585798100_B23","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/jc.2017-02662","article-title":"PLIN1 haploinsufficiency is not associated with lipodystrophy","volume":"103","author":"Laver","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2022032220585798100_B24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajmg.a.37880","article-title":"Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy","volume":"173","author":"Zolotov","year":"2017","journal-title":"Am J Med Genet A"},{"key":"2022032220585798100_B25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2022032220585798100_B26","doi-asserted-by":"crossref","first-page":"e86870","DOI":"10.1172\/jci.insight.86870","article-title":"Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy","volume":"1","author":"Garg","year":"2016","journal-title":"JCI Insight"},{"key":"2022032220585798100_B27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/tra.12717","article-title":"CIDE family proteins control lipid homeostasis and the development of metabolic diseases","volume":"21","author":"Chen","year":"2020","journal-title":"Traffic"},{"key":"2022032220585798100_B28","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M509612200","article-title":"A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation","volume":"281","author":"Gale","year":"2006","journal-title":"J Biol Chem"},{"key":"2022032220585798100_B29","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db12-0004","article-title":"Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations","volume":"61","author":"Subauste","year":"2012","journal-title":"Diabetes"},{"key":"2022032220585798100_B30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmet.2014.12.013","article-title":"Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis","volume":"4","author":"Talukder","year":"2015","journal-title":"Mol Metab"},{"key":"2022032220585798100_B31","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1083\/jcb.201809067","article-title":"Cryo-electron microscopy structure of the lipid droplet-formation protein seipin","volume":"217","author":"Sui","year":"2018","journal-title":"J Cell Biol"},{"key":"2022032220585798100_B32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.devcel.2018.09.010","article-title":"Human SEIPIN binds anionic phospholipids","volume":"47","author":"Yan","year":"2018","journal-title":"Dev Cell"},{"key":"2022032220585798100_B33","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms21218208","article-title":"SEIPIN: a key factor for nuclear lipid droplet generation and lipid homeostasis","volume":"21","author":"Jin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022032220585798100_B34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1007\/s00125-013-3029-3","article-title":"Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms","volume":"56","author":"Sim","year":"2013","journal-title":"Diabetologia"},{"key":"2022032220585798100_B35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.celrep.2016.10.037","article-title":"SEIPIN regulates lipid droplet expansion and adipocyte development by modulating the activity of glycerol-3-phosphate acyltransferase","volume":"17","author":"Pagac","year":"2016","journal-title":"Cell Rep"},{"key":"2022032220585798100_B36","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41598-020-59982-5","article-title":"Oligomers of the lipodystrophy protein seipin may co-ordinate GPAT3 and AGPAT2 enzymes to facilitate adipocyte differentiation","volume":"10","author":"Sim","year":"2020","journal-title":"Sci Rep"},{"key":"2022032220585798100_B37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/hmg\/ddz300","article-title":"GPAT3 deficiency alleviates insulin resistance and hepatic steatosis in a mouse model of severe congenital generalized lipodystrophy","volume":"29","author":"Gao","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2022032220585798100_B38","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume":"20","author":"Cui","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2022032220585798100_B39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molmet.2018.01.019","article-title":"Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease","volume":"10","author":"Mcilroy","year":"2018","journal-title":"Mol Metab"},{"key":"2022032220585798100_B40","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","article-title":"The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation","volume":"57","author":"Payne","year":"2008","journal-title":"Diabetes"},{"key":"2022032220585798100_B41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1194\/jlr.M060244","article-title":"Berardinelli-Seip congenital lipodystrophy 2 regulates adipocyte lipolysis, browning, and energy balance in adult animals","volume":"56","author":"Zhou","year":"2015","journal-title":"J Lipid Res"},{"key":"2022032220585798100_B42","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.2337\/db16-0327","article-title":"FGF21 improves the adipocyte dysfunction related to seipin deficiency","volume":"65","author":"Dollet","year":"2016","journal-title":"Diabetes"},{"key":"2022032220585798100_B43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/dmm.042655","article-title":"Ablation of Bscl2\/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy","volume":"13","author":"Mcilroy","year":"2020","journal-title":"Dis Model Mech"},{"key":"2022032220585798100_B44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-cellbio-100617-062737","article-title":"Caveolae: structure, function, and relationship to disease","volume":"34","author":"Parton","year":"2018","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2022032220585798100_B45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1530\/EJE-21-0915","article-title":"Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia","volume":"185","author":"Karhan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2022032220585798100_B46","doi-asserted-by":"crossref","first-page":"166167","DOI":"10.1016\/j.bbadis.2021.166167","article-title":"Decreased caveolae in AGPAT2 lacking adipocytes is independent of changes in cholesterol or sphingolipid levels: a whole cell and plasma membrane lipidomic analysis of adipogenesis","volume":"1867","author":"Gonz\u00e1lez-H\u00f3dar","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2022032220585798100_B47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tem.2016.03.016","article-title":"Marrow adipose tissue: trimming the fat","volume":"27","author":"Scheller","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"2022032220585798100_B48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2016.05.012","article-title":"The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity","volume":"24","author":"Jeffery","year":"2016","journal-title":"Cell Metab"},{"key":"2022032220585798100_B49","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev"},{"key":"2022032220585798100_B50","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/db06-0389","article-title":"Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice","volume":"55","author":"Gray","year":"2006","journal-title":"Diabetes"},{"key":"2022032220585798100_B51","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/db10-0673","article-title":"Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction","volume":"59","author":"Pendse","year":"2010","journal-title":"Diabetes"},{"key":"2022032220585798100_B52","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/dom.13370","article-title":"P465L-PPAR\u03b3 mutation confers partial resistance to the hypolipidaemic action of fibrates","volume":"20","author":"Rodriguez-Cuenca","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2022032220585798100_B53","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/db20-1001","article-title":"Adipocyte-specific deletion of lamin A\/C largely models human familial partial lipodystrophy type 2","volume":"70","author":"Corsa","year":"2021","journal-title":"Diabetes"},{"key":"2022032220585798100_B54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmet.2009.01.002","article-title":"Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy","volume":"9","author":"Cort\u00e9s","year":"2009","journal-title":"Cell Metab"},{"key":"2022032220585798100_B55","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.molmet.2020.02.014","article-title":"Berardinelli-Seip congenital lipodystrophy 2\/SEIPIN determines brown adipose tissue maintenance and thermogenic programing","volume":"36","author":"Zhou","year":"2020","journal-title":"Mol Metab"},{"key":"2022032220585798100_B56","doi-asserted-by":"crossref","first-page":"e49452","DOI":"10.1371\/journal.pone.0049452","article-title":"Human BAT possesses molecular signatures that resemble beige\/brite cells","volume":"7","author":"Sharp","year":"2012","journal-title":"PLoS One"},{"key":"2022032220585798100_B57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbalip.2016.02.018","article-title":"Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice","volume":"1861","author":"Wang","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022032220585798100_B58","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1152\/ajpendo.00180.2018","article-title":"Adipose tissue transplantation ameliorates lipodystrophy-associated metabolic disorders in seipin-deficient mice","volume":"316","author":"Wang","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022032220585798100_B59","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1096\/fj.201701427R","article-title":"Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk","volume":"32","author":"Liu","year":"2018","journal-title":"FASEB J"},{"key":"2022032220585798100_B60","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium\u2013glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"2022032220585798100_B61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11892-018-1100-7","article-title":"Update on therapeutic options in lipodystrophy","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2022032220585798100_B62","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/jocn.14342","article-title":"\u201cWe\u2019re stuck with what we\u2019ve got\u201d: the impact of lipodystrophy on body image","volume":"27","author":"Adams","year":"2018","journal-title":"J Clin Nurs"},{"key":"2022032220585798100_B63","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2337\/diacare.23.10.1545","article-title":"Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy","volume":"23","author":"Garg","year":"2000","journal-title":"Diabetes Care"},{"key":"2022032220585798100_B64","first-page":"dgab725","article-title":"Impaired muscle mitochondrial function in familial partial lipodystrophy","author":"Simha","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/71\/4\/589\/671738\/dbi210006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/71\/4\/589\/671738\/dbi210006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T20:49:37Z","timestamp":1726865377000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/71\/4\/589\/144873\/When-Adipose-Tissue-Lets-You-Down-Understanding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,22]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dbi21-0006","relation":{},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}